Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02955069
Title Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN | BEL | AUT | AUS

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 91010 United States Details
Rocky Mountain Cancer Centers SC-2 Denver Colorado 80218 United States Details
H Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
Mayo Clinic - Rochester Rochester Minnesota 55905 United States Details
Montefiore Medical Center Bronx New York 10461 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of TX MD Anderson Cancer Center Houston Texas 77030 United States Details
Novartis Investigative Site St Leonards New South Wales 2065 Australia Details
Novartis Investigative Site Wien A-1090 Austria Details
Novartis Investigative Site Brussels BE-B-1200 Belgium Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Toronto Ontario M4N 3M5 Canada Details
Novartis Investigative Site Montreal Quebec H3T 1E2 Canada Details
Novartis Investigative Site Lyon 69437 France Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Toulouse Cedex 4 31054 France Details
Novartis Investigative Site Erlangen 91054 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Mainz 55131 Germany Details
Novartis Investigative Site Marburg 35039 Germany Details
Novartis Investigative Site Bologna BO 40138 Italy Details
Novartis Investigative Site Meldola FC 47014 Italy Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Milano MI 20141 Italy Details
Novartis Investigative Site Roma RM 00189 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Novartis Investigative Site Nagoya Aichi 464 8681 Japan Details
Novartis Investigative Site Kashiwa Chiba 277 8577 Japan Details
Novartis Investigative Site Fukuoka city Fukuoka 812-8582 Japan Details
Novartis Investigative Site Chuo ku Tokyo 104 0045 Japan Details
Novartis Investigative Site Amsterdam 1066 CX Netherlands Details
Novartis Investigative Site Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site London NW3 2PR United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field